Trial Profile
An Open-label, 2-period, Single-sequence, Crossover Study to Evaluate the Effect of Multiple Oral Dosing of Itraconazole on BCT197 Systemic Exposure in Healthy Male Participants
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 May 2018
Price :
$35
*
At a glance
- Drugs Acumapimod (Primary) ; Itraconazole
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- Sponsors Mereo BioPharma
- 17 May 2018 Status changed from recruiting to completed.
- 18 Apr 2018 New trial record